1. Home
  2. ITOS vs ADV Comparison

ITOS vs ADV Comparison

Compare ITOS & ADV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ITOS
  • ADV
  • Stock Information
  • Founded
  • ITOS 2011
  • ADV 1987
  • Country
  • ITOS United States
  • ADV United States
  • Employees
  • ITOS N/A
  • ADV N/A
  • Industry
  • ITOS Biotechnology: Biological Products (No Diagnostic Substances)
  • ADV Business Services
  • Sector
  • ITOS Health Care
  • ADV Consumer Discretionary
  • Exchange
  • ITOS Nasdaq
  • ADV Nasdaq
  • Market Cap
  • ITOS 381.2M
  • ADV 428.1M
  • IPO Year
  • ITOS 2020
  • ADV N/A
  • Fundamental
  • Price
  • ITOS $10.17
  • ADV $1.60
  • Analyst Decision
  • ITOS Hold
  • ADV Strong Buy
  • Analyst Count
  • ITOS 6
  • ADV 1
  • Target Price
  • ITOS $10.60
  • ADV $2.50
  • AVG Volume (30 Days)
  • ITOS 1.5M
  • ADV 808.5K
  • Earning Date
  • ITOS 08-07-2025
  • ADV 08-07-2025
  • Dividend Yield
  • ITOS N/A
  • ADV N/A
  • EPS Growth
  • ITOS N/A
  • ADV N/A
  • EPS
  • ITOS N/A
  • ADV N/A
  • Revenue
  • ITOS $35,000,000.00
  • ADV $3,526,704,000.00
  • Revenue This Year
  • ITOS N/A
  • ADV N/A
  • Revenue Next Year
  • ITOS N/A
  • ADV N/A
  • P/E Ratio
  • ITOS N/A
  • ADV N/A
  • Revenue Growth
  • ITOS 177.89
  • ADV N/A
  • 52 Week Low
  • ITOS $4.80
  • ADV $1.04
  • 52 Week High
  • ITOS $18.13
  • ADV $4.16
  • Technical
  • Relative Strength Index (RSI)
  • ITOS 58.43
  • ADV 54.50
  • Support Level
  • ITOS $10.10
  • ADV $1.33
  • Resistance Level
  • ITOS $10.47
  • ADV $1.82
  • Average True Range (ATR)
  • ITOS 0.12
  • ADV 0.13
  • MACD
  • ITOS -0.06
  • ADV 0.01
  • Stochastic Oscillator
  • ITOS 23.08
  • ADV 55.67

About ITOS iTeos Therapeutics Inc.

ITeos Therapeutics Inc is a biopharmaceutical company. It designs novel product candidates with optimized pharmacologic properties to improve clinical outcomes by restoring the immune response against cancer. The company's product candidates include EOS-850 which is an Adenosine A2A receptor-specific antagonist, and EOS-448 which is an ADCC-enabled, anti-TIGIT immune checkpoint blocking antibody among other drug candidates.

About ADV Advantage Solutions Inc.

Advantage Solutions Inc is a omnichannel retail solutions agency in North America, uniquely positioned at the intersection of consumer-packaged goods (CPG) brands and retailers.

Share on Social Networks: